CCL22 and crescentic glomerulonephritis: Our study has revealed a new remission mechanism whereby effector Tregs migrate into the crescentic glomerulonephritis via the CCL22/17–CCR4 axis that is facilitated by M2‐like type macrophages that are induced by IL‐6R blockade.